RCUS
Price
$24.56
Change
+$1.82 (+8.00%)
Updated
Jan 14 closing price
Capitalization
3.04B
41 days until earnings call
Intraday BUY SELL Signals
TYRA
Price
$29.20
Change
+$0.39 (+1.35%)
Updated
Jan 14 closing price
Capitalization
1.56B
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RCUS vs TYRA

Header iconRCUS vs TYRA Comparison
Open Charts RCUS vs TYRABanner chart's image
Arcus Biosciences
Price$24.56
Change+$1.82 (+8.00%)
Volume$2.09M
Capitalization3.04B
Tyra Biosciences
Price$29.20
Change+$0.39 (+1.35%)
Volume$300.67K
Capitalization1.56B
RCUS vs TYRA Comparison Chart in %
View a ticker or compare two or three
VS
RCUS vs. TYRA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a Hold and TYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (RCUS: $24.56 vs. TYRA: $29.20)
Brand notoriety: RCUS and TYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCUS: 110% vs. TYRA: 55%
Market capitalization -- RCUS: $3.04B vs. TYRA: $1.56B
RCUS [@Biotechnology] is valued at $3.04B. TYRA’s [@Biotechnology] market capitalization is $1.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCUS’s FA Score shows that 0 FA rating(s) are green whileTYRA’s FA Score has 1 green FA rating(s).

  • RCUS’s FA Score: 0 green, 5 red.
  • TYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, TYRA is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCUS’s TA Score shows that 7 TA indicator(s) are bullish while TYRA’s TA Score has 4 bullish TA indicator(s).

  • RCUS’s TA Score: 7 bullish, 3 bearish.
  • TYRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RCUS is a better buy in the short-term than TYRA.

Price Growth

RCUS (@Biotechnology) experienced а +5.86% price change this week, while TYRA (@Biotechnology) price change was -3.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

RCUS is expected to report earnings on Feb 25, 2026.

TYRA is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($3.04B) has a higher market cap than TYRA($1.56B). TYRA YTD gains are higher at: 11.069 vs. RCUS (3.063). TYRA has higher annual earnings (EBITDA): -125.43M vs. RCUS (-323M). RCUS has more cash in the bank: 831M vs. TYRA (275M). TYRA has less debt than RCUS: TYRA (5.92M) vs RCUS (111M). RCUS has higher revenues than TYRA: RCUS (240M) vs TYRA (0).
RCUSTYRARCUS / TYRA
Capitalization3.04B1.56B195%
EBITDA-323M-125.43M258%
Gain YTD3.06311.06928%
P/E RatioN/AN/A-
Revenue240M0-
Total Cash831M275M302%
Total Debt111M5.92M1,875%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RCUSTYRA
RSI
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
RCUS
Daily Signal:
Gain/Loss:
TYRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMIX32.130.02
+0.06%
Goldman Sachs Emerging Markets Eq Instl
EXOSX37.83-0.01
-0.03%
Manning & Napier Overseas Series I
AISZX19.38-0.01
-0.05%
Alger SmallCap Growth Institutional Z-2
PRDGX83.06-0.07
-0.08%
T. Rowe Price Dividend Growth
TBARX30.04-0.10
-0.33%
Touchstone Balanced R6

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+8.00%
XNCR - RCUS
56%
Loosely correlated
+3.66%
IDYA - RCUS
50%
Loosely correlated
+5.53%
KURA - RCUS
48%
Loosely correlated
+1.63%
TYRA - RCUS
47%
Loosely correlated
+1.35%
SYRE - RCUS
47%
Loosely correlated
+5.17%
More

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with NRIX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
+1.35%
NRIX - TYRA
53%
Loosely correlated
+0.58%
NUVL - TYRA
50%
Loosely correlated
+6.59%
RCUS - TYRA
47%
Loosely correlated
+8.00%
RVMD - TYRA
45%
Loosely correlated
+1.06%
XNCR - TYRA
45%
Loosely correlated
+3.66%
More